PS.
PublicSupply
account_balanceBuyersbusinessSuppliersdescriptionNotices
BuyersSuppliersNotices
verified_userData sourced from Contracts Finder, Find a Tender, and Companies House.
Contracts Finder ↗Find a Tender ↗Procurement Act 2023 ↗
  1. Home›
  2. Suppliers›
  3. Mercury Pharmaceuticals Limited
MP

Mercury Pharmaceuticals Limited

London
Large

ADVANZ PHARMA is a global pharmaceutical company focused on improving patients' lives by providing specialty, hospital, and rare disease medicines. They partner with biopharma and pharmaceutical companies to commercialize innovative medicines worldwide.

advanzpharma.com ↗

Summary from the supplier’s website — unverified

Compare peers
Awarded
£848.0m
Live
59
Buyers
12
12m
£759.8m
At a glance
  • Quick answer
Profile
  • Social value
  • ESG & policies
  • Capabilities4
  • Buyer references
  • Accreditations
Track record · verified
  • KPI performance
  • Contracts59 / 81
  • Top buyers12
  • Category mix
  • Geography
  • Peers5
Trust & risk
  • Red flags0
  • Compliance
  • Modifications
  • News
Company
  • Companies House
  • Financial
  • Org tree
Quick answer — Mercury Pharmaceuticals LimitedUpdated 13 Jul 2026

At a glance · for buyers and watchdogs

Mercury Pharmaceuticals Limited has won £848.0m across 12 public-sector buyers, with 59 live contracts. No active Companies House risk flags.

Why: top buyer NHS England at 96% · 0 active risk flags · 0 modifications.

Decision signals
0Active red flags
ActiveCompany status
59 of 81Live contracts
96%Top-buyer concentration
—Category exposure
0Contract modifications
If you're a buyer:CapabilitiesReferencesKPIComplianceWatchdog?FlagsModificationsConcentrationNews

Social value

Commitments mapped to the Government Social Value Model themes.

⚑ Self-reported
—

No social-value commitments yet

Jobs, skills, environmental, inequality and community commitments appear here once a claimed supplier attributes them to awarded contracts, or once we detect them on the supplier’s website.

ESG & policies vault · 0/5

Key governance & sustainability policies. Published documents link out; missing ones are greyed.

↔ Cross-checked
Net-zero planNot provided✓
Modern slavery statementNot provided✓
EDI policyNot provided✓
Anti-briberyNot provided✓
Data protectionNot provided✓

Capabilities

What this supplier does, where they sit, who they sell to.

◐ From website & notices
Sectors served · 1/8
Central government✓
Local government✓
NHS & health✓
Housing✓
Utilities & energy✓
Financial services✓
Education✓
Defence✓
Services · 3
Specialty MedicinesProviding a wide range of high-quality specialty medicines across various therapeutic areas.
BiosimilarsBuilding a diverse portfolio of biosimilars to enhance treatment options. ↗Commercialization PartnershipsPartnering with over 300 companies for production, development, and commercialization. ↗
Frameworks & DPS · 4 from notices
  • NHS Framework Agreement - North of England - Tranche BNHS England · £17.4m
  • NHS Framework Agreement for Branded medicines - NationalNHS England · £6.1m
  • Supportive Medicines including ITU, EOL & AntibioticsDepartment of Health and Social Care (T&T) · £1.7m
  • NHS National Pharmaceuticals Transition 2022_1NHS England and NHS Improvement · £944k

Extracted automatically from advanzpharma.com on Jul 2026. Not independently verified — treat as the supplier’s own marketing claims.

Case studies

Delivery stories the supplier has published, with sector and outcome.

⚑ Self-reported
—

No case studies yet

Once a claimed supplier publishes delivery stories — the buyer, the sector, what was delivered and the outcome — they appear here.

Buyer references

Named public-sector contacts who have agreed to act as a reference.

✓ Confirmed by buyer
—

No buyer references yet

Public-sector buyers can confirm they'll act as a reference for this supplier. Confirmed references — with the contract they relate to — show here.

Accreditations & memberships

Independently issued. Verification dates cross-checked against issuer registers.

↔ Cross-checked
—

No accreditations recorded

B-Corp, ISO, Cyber Essentials, Living Wage and similar credentials appear here once added by a claimed supplier and cross-checked against the issuing register.

KPI performance

Delivery, budget and satisfaction scores reported quarterly by buyers.

✓ Verified
84

No verified KPI scores yet

Once buyers report contract KPIs — delivery on time, on budget, satisfaction, adoption and accessibility — a weighted grade and breakdown appear here.

Contracts · 59 live · 22 historic

Pulled from Contracts Finder & Find a Tender. Most recent first.

✓ From notices
TitleBuyerCPVAwardedValueTermStatus
Transitional Drugs 7
NHS Wales Shared Services Partnership-Procurement Services (hosted by Velindre University NHS Trust)—01 Jul 2026£16.8m2 yrspending
NHS National Branded Interim - 1 June 2026
NHS England—01 Jun 2026£529.1m1.9 yrspending
Generic Drugs – Injections/Infusions 2
NHS Wales Shared Services Partnership-Procurement Services (hosted by Velindre University NHS Trust)—01 Jul 2026£5.9m12 mopending
NHS National Generic Pharmaceuticals - Wave 15c
NHS England—01 Jun 2026£37.2m16 mopending
NHS National Framework Agreement for Omalizumab
NHS England—01 Feb 2026£87.4m1.6 yrspending
Transitional Drugs 5
NHS Wales Shared Services Partnership-Procurement Services (hosted by Velindre University NHS Trust)—01 Jan 2026£5.6m2 yrspending
NHS National Framework for Generics Housekeeping
NHS England—01 Feb 2026£17.8m12 mopending
NHS National Framework for Golimumab Injection
NHS England—01 Nov 2025£60.0m12 mopending
NHS National Framework - Generics Housekeeping/Supply Chain Resilience Products
NHS England3360000001 Jun 2025£376k2 yrsLive
NHS National Framework for Transition products commencing 1 October 2024
NHS England3360000001 Oct 2024£1.4m1.7 yrsClosed
Total live value £11.6m · mean award £10.5m1–10 of 81

Top buyers · 12 buyers · top 3 = 100%

Share of awarded value. Concentration fires above 40% for any single buyer.

✓ From notices
1
NHS England
37 contracts
96%
since 2018
2
NHS Wales Shared Services Partnership-Procurement Services (hosted by Velindre University NHS Trust)
4 contracts
3%
since 2025
3
Department of Health and Social Care (T&T)
6 contracts
1%
since 2020
4
NHS England and NHS Improvement
1 contract
0%
since 2022
5
Procurement and Logistics Service, Business Services Organisation
1 contract
0%
6
The Common Services Agency (more commonly known as NHS National Services Scotland) (NSS)
12 contracts
0%
7
The NHS Commissioning Board (operating under the name of NHS England)
3 contracts
0%
8
Regional Business Services Organisation Procurement and Logistics Service
1 contract
0%
9
Procurement and Logistics Service
3 contracts
0%
10
Velindre NHS Trust, NHS Shared Services Partnership - Procurement Services (on behalf of All Wales Health Boards and Trusts)
11 contracts
0%

Geography

Distribution of awarded value by buyer region.

✓ From notices
UK · schematic only
Yorkshire38 contracts
97%
Wales16 contracts
3%
Northern Ireland6 contracts
0%
Scotland12 contracts
0%
North West3 contracts
0%

Peers

Suppliers with overlapping CPVs & buyers (last 24m). Mercury Pharmaceuticals Limited highlighted.

✓ From notices
SupplierSME?Awarded · 24mContracts
MP
Mercury Pharmaceuticals Limited
No£759.8m—
DR
Dr Reddy's Laboratories (UK) Ltd
Yes£121.0m17
JA
Janssen-Cilag Ltd
Yes£117.6m16
AB
AbbVie Ltd
Yes£95.2m11
TA
Thornton and Ross Ltd
Yes£72.5m9
AC
ACCORD-UK LTD
Yes£71.2m18
Compare peers →

Red flags · 0 active

Automated scan of Companies House status, charges and insolvency records.

✓ Verified
✓ Clean. No active risk signals from Companies House status, charges or insolvency records.

Compliance scorecard

Derived from Companies House filings — not a full supplier-assurance check.

↔ Cross-checked
Trading status
Active
Live at Companies House
Annual accounts
Up to date
Last made up to 31 Dec 2024
Confirmation statement
Due in 7d
Next due 21 Jul 2026
Outstanding charges
0
No charges registered
Insolvency history
None
No insolvency cases registered
Certifications (ISO, Cyber Essentials, Living Wage, B-Corp, modern-slavery) are supplier self-reported and appear once a claimed profile adds them.

Modifications

Variations to awarded contracts logged under Procurement Act 2023 s.74.

✓ From notices
±

No modifications recorded

No published contract variations for this supplier. Modification notices appear here as they are issued under the Procurement Act 2023.

News mentions

UK trade press & nationals, matched to this supplier.

◰

No news mentions found

We haven't matched any recent UK press coverage to this supplier. Mentions appear here automatically as they're published.

Companies House

Live sync — registered details, directors, PSC and SIC codes.

✓ Live sync

Registered details

Company no.
02619880
Status
Active
Type
Private limited
Incorporated
12 Jun 1991
Reg. office
Dashwood House, 69 Old Broad Street, London, EC2M 1QS
SIC codes
21100
Last accounts
31 Dec 2024
Next accounts due
30 Sept 2026

Directors & PSC

  • FERRY, Melvin Jeremy, Mr. — director
    Appointed 06 Feb 2025
  • TMF CORPORATE ADMINISTRATION SERVICES LIMITED — corporate secretary
    Appointed 16 Mar 2022
  • STICKLER, Andreas — director
    Appointed 21 Jan 2022
  • Mercury Pharma Group Limited — person with significant control
    ownership of shares 75 to 100 percent · voting rights 75 to 100 percent · right to appoint and remove directors

Financial

Filed accounts from Companies House.

↔ From Cos House
£

No financial filings on record

Turnover, profit and headcount appear here once audited or micro-entity accounts are filed at Companies House.

Org tree

Group structure and ownership.

↔ From Cos House
MERCURY PHARMACEUTICALS LIMITED
02619880 · this company

Independent. No parent company or subsidiaries recorded at Companies House for this entity.